234 related articles for article (PubMed ID: 18498446)
1. Optimized stepwise combination algorithms of non-invasive liver fibrosis scores including Hepascore in hepatitis C virus patients.
Bourliere M; Penaranda G; Ouzan D; Renou C; Botta-Fridlund D; Tran A; Rosenthal E; Wartelle-Bladou C; Delasalle P; Oules V; Portal I; Castellani P; Lecomte L; Rosenthal-Allieri MA; Halfon P
Aliment Pharmacol Ther; 2008 Aug; 28(4):458-67. PubMed ID: 18498446
[TBL] [Abstract][Full Text] [Related]
2. Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies.
Bourliere M; Penaranda G; Renou C; Botta-Fridlund D; Tran A; Portal I; Lecomte L; Castellani P; Rosenthal-Allieri MA; Gerolami R; Ouzan D; Deydier R; Degott C; Halfon P
J Viral Hepat; 2006 Oct; 13(10):659-70. PubMed ID: 16970597
[TBL] [Abstract][Full Text] [Related]
3. Non-invasive biomarkers of liver fibrosis in haemophilia patients with hepatitis C: can you avoid liver biopsy?
Maor Y; Bashari D; Kenet G; Lubetsky A; Luboshitz J; Schapiro JM; Pénaranda G; Bar-Meir S; Martinowitz U; Halfon P
Haemophilia; 2006 Jul; 12(4):372-9. PubMed ID: 16834736
[TBL] [Abstract][Full Text] [Related]
4. Optimized cutoffs improve performance of the aspartate aminotransferase to platelet ratio index for predicting significant liver fibrosis in human immunodeficiency virus/hepatitis C virus co-infection.
Carvalho-Filho RJ; Schiavon LL; Narciso-Schiavon JL; Sampaio JP; Lanzoni VP; Ferraz ML; Silva AE
Liver Int; 2008 Apr; 28(4):486-93. PubMed ID: 18339075
[TBL] [Abstract][Full Text] [Related]
5. Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C.
Sebastiani G; Vario A; Guido M; Noventa F; Plebani M; Pistis R; Ferrari A; Alberti A
J Hepatol; 2006 Apr; 44(4):686-93. PubMed ID: 16490278
[TBL] [Abstract][Full Text] [Related]
6. Improving estimation of liver fibrosis using combination and newer noninvasive biomarker scoring systems in hepatitis C-infected haemophilia patients.
Maor Y; Calès P; Bashari D; Kenet G; Lubetsky A; Luboshitz J; Schapiro JM; Pénaranda G; Bar-Meir S; Martinowitz U; Halfon P
Haemophilia; 2007 Nov; 13(6):722-9. PubMed ID: 17973848
[TBL] [Abstract][Full Text] [Related]
7. Comparison of non-invasive liver fibrosis biomarkers in HIV/HCV co-infected patients: the fibrovic study--ANRS HC02.
Cacoub P; Carrat F; Bédossa P; Lambert J; Pénaranda G; Perronne C; Pol S; Halfon P
J Hepatol; 2008 May; 48(5):765-73. PubMed ID: 18314219
[TBL] [Abstract][Full Text] [Related]
8. Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C.
Leroy V; Hilleret MN; Sturm N; Trocme C; Renversez JC; Faure P; Morel F; Zarski JP
J Hepatol; 2007 May; 46(5):775-82. PubMed ID: 17321634
[TBL] [Abstract][Full Text] [Related]
9. Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation.
Toniutto P; Fabris C; Bitetto D; Falleti E; Avellini C; Rossi E; Smirne C; Minisini R; Pirisi M
J Gastroenterol Hepatol; 2007 Nov; 22(11):1904-8. PubMed ID: 17914968
[TBL] [Abstract][Full Text] [Related]
10. Comparison of three algorithms of non-invasive markers of fibrosis in chronic hepatitis C.
Sebastiani G; Halfon P; Castera L; Mangia A; Di Marco V; Pirisi M; Voiculescu M; Bourliere M; Alberti A
Aliment Pharmacol Ther; 2012 Jan; 35(1):92-104. PubMed ID: 22035045
[TBL] [Abstract][Full Text] [Related]
11. Accuracy of simple biochemical tests in identifying liver fibrosis in patients co-infected with human immunodeficiency virus and hepatitis C virus.
Tural C; Tor J; Sanvisens A; Pérez-Alvarez N; Martínez E; Ojanguren I; García-Samaniego J; Rockstroh J; Barluenga E; Muga R; Planas R; Sirera G; Rey-Joly C; Clotet B
Clin Gastroenterol Hepatol; 2009 Mar; 7(3):339-45. PubMed ID: 19171202
[TBL] [Abstract][Full Text] [Related]
12. Comparison of test performance profile for blood tests of liver fibrosis in chronic hepatitis C.
Halfon P; Bacq Y; De Muret A; Penaranda G; Bourliere M; Ouzan D; Tran A; Botta D; Renou C; Bréchot MC; Degott C; Paradis V
J Hepatol; 2007 Mar; 46(3):395-402. PubMed ID: 17156890
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease.
Naveau S; Gaudé G; Asnacios A; Agostini H; Abella A; Barri-Ova N; Dauvois B; Prévot S; Ngo Y; Munteanu M; Balian A; Njiké-Nakseu M; Perlemuter G; Poynard T
Hepatology; 2009 Jan; 49(1):97-105. PubMed ID: 19053048
[TBL] [Abstract][Full Text] [Related]
14. The combination of a blood test and Fibroscan improves the non-invasive diagnosis of liver fibrosis.
Boursier J; Vergniol J; Sawadogo A; Dakka T; Michalak S; Gallois Y; Le Tallec V; Oberti F; Fouchard-Hubert I; Dib N; Rousselet MC; Konaté A; Amrani N; de Ledinghen V; Calès P
Liver Int; 2009 Nov; 29(10):1507-15. PubMed ID: 19725892
[TBL] [Abstract][Full Text] [Related]
15. Comparison of transient elastography (FibroScan), FibroTest, APRI and two algorithms combining these non-invasive tests for liver fibrosis staging in HIV/HCV coinfected patients: ANRS CO13 HEPAVIH and FIBROSTIC collaboration.
Castera L; Winnock M; Pambrun E; Paradis V; Perez P; Loko MA; Asselineau J; Dabis F; Degos F; Salmon D
HIV Med; 2014 Jan; 15(1):30-9. PubMed ID: 24007567
[TBL] [Abstract][Full Text] [Related]
16. Improved diagnostic accuracy of blood tests for severe fibrosis and cirrhosis in chronic hepatitis C.
Boursier J; Bacq Y; Halfon P; Leroy V; de Ledinghen V; de Muret A; Bourlière M; Sturm N; Foucher J; Oberti F; Rousselet MC; Calès P
Eur J Gastroenterol Hepatol; 2009 Jan; 21(1):28-38. PubMed ID: 19060630
[TBL] [Abstract][Full Text] [Related]
17. Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis C.
Castéra L; Sebastiani G; Le Bail B; de Lédinghen V; Couzigou P; Alberti A
J Hepatol; 2010 Feb; 52(2):191-8. PubMed ID: 20006397
[TBL] [Abstract][Full Text] [Related]
18. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C.
Lackner C; Struber G; Liegl B; Leibl S; Ofner P; Bankuti C; Bauer B; Stauber RE
Hepatology; 2005 Jun; 41(6):1376-82. PubMed ID: 15915455
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients.
Patel K; Gordon SC; Jacobson I; Hézode C; Oh E; Smith KM; Pawlotsky JM; McHutchison JG
J Hepatol; 2004 Dec; 41(6):935-42. PubMed ID: 15582126
[TBL] [Abstract][Full Text] [Related]
20. Validation of a simple model for predicting liver fibrosis in HIV/hepatitis C virus-coinfected patients.
Al-Mohri H; Cooper C; Murphy T; Klein MB
HIV Med; 2005 Nov; 6(6):375-8. PubMed ID: 16268817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
